Exyte acquires TTP Group to accelerate growth of Biopharma and Life Sciences business

The goal is to create a strong partner for the booming European biotechnology and pharmaceutical industry

10-Sep-2024 - Exyte, a global leader in the design, engineering, and delivery of high-tech facilities, intends to acquire TTP Group ("TTP"), a leading firm in consulting and engineering for the pharmaceutical and chemical industry in Europe. TTP's portfolio encompasses a wide range of engineering services, ...

Merck to Become First Provider to Offer Fully Integrated mRNA Services

New sites at Darmstadt and Hamburg complement Merck’s global integrated mRNA service network

28-Sep-2023 - Merck became the first CTDMO (contract testing, development and manufacturing organization) to offer integrated services for all critical stages of mRNA development, manufacturing, and commercialization, including products and testing. The company opened two new GMP-grade mRNA drug substance ...

Green chemistry needs more green toxicology

Sustainable bioeconomy: Development of environmentally friendly bio-shampoos and plant protection agent technologies

16-Feb-2022 - With the early assessment of sustainable, newly developed chemicals and products it is possible to assess a potential risk of toxic substances being released at a later point in product cascades. This has been revealed in a proof-of-concept study jointly coordinated by Goethe University Frankfurt ...

Definitive Agreement to Acquire Exelead will Strengthen Merck’s CDMO Offering for mRNA

Targeted acquisition to accelerate novel modalities service offering

07-Jan-2022 - Merck has signed a definitive agreement to acquire Exelead, a biopharmaceutical contract development and manufacturing organization (CDMO), for approximately USD780million in cash. Exelead specializes in complex injectable formulations, including Lipid Nanoparticle (LNP) based drug delivery ...

CHEMIE.DE’s Cutting Edge Company Directory

The most direct and fast way to find meaningful data about companies in chemistry, life sciences and analytics

09-Nov-2016 - More than 5 million users now count on the vast body of information available on the CHEMIE.DE science and industry internet portals. The extensive company directory, in particular, offers a fast and convenient way of finding information on more than 15,000 companies in chemistry, life sciences ...

CHEMIE.DE’s 15th anniversary: from a university project to a specialist for industry internet portals and online marketing

Europe's leading information platform offers unique services to science industries

15-Jun-2015 - CHEMIE.DE celebrates its 15th anniversary, having grown into Europe's leading provider of scientific online portals since the year 2000. The Berlin-based company’s broad spectrum of services is unique: on its five science-related online portals for industry professionals - www.chemie.de, ...

Galapagos wins 2010 European Biotechnica Award

07-Oct-2010 - Galapagos NV announced that it won the European Biotechnica Award at last night's ceremony in Hannover. Presented each year by the Deutsche Messe, the Biotechnica award recognizes European-based biotechnology companies that have developed particularly innovative products, services and business ...

BIOTECHNICA 2010 with new focus topics

21-Sep-2010 - BIOTECHNICA 2010 is open for business in Hannover from 5 to 7 October, with new focus topics and more wide-ranging coverage. Europe’s leading biotech and life sciences event focuses on biotech applications in the fields of medicine, pharmaceuticals, food, agriculture, manufacturing industry and ...

Eurofins MWG Operon Signs Contract to Supply Oligonucleotides to Research Councils

11-Aug-2010 - Eurofins MWG Operon, and RCUK Shared Services Centre Limited (RCUK SSC Ltd) have signed a three year contract for the supply of synthetic DNA & RNA oligonucleotides. This long term contract builds on the relationship developed as a preferred supplier to the Medical Research Council (MRC) during ...

febit Announces Operational Restructuring

Strategic focus on partnerships with clinical researchers, diagnostic and pharma industry for its microRNA (miRNA) biomarker technology

24-Jun-2010 - febit announced a restructuring as a consequence of its strategic focus on blood-based microRNA biomarker discovery, febit’s major business development in 2009/2010, and on partnerships and intellectual property (IP) commercialization. The new focus includes the collaboration and provision of ...